Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Canntab Therapeutics Ltd CTABF


Primary Symbol: C.PILL

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:PILL)

Canadian Investment Regulatory Organization Trading Halt - PILL

Canada NewsWire October 5, 2023

Canntab Therapeutics Limited Provides Update on Application for Management Cease Trade Order

Newsfile September 18, 2023

IIROC Trade Resumption - PILL

Canada NewsWire November 22, 2022

Canntab Announces Corporate Update

Accesswire November 22, 2022

IIROC Trading Halt - PILL

Canada NewsWire November 21, 2022

CANNTAB ANNOUNCES ITS ENTRANCE INTO THE NOVA SCOTIA CANNABIS MARKET

Canada NewsWire August 22, 2022

CANNTAB ANNOUNCES APPOINTMENT OF RICHARD GOLDSTEIN AS INTERIM CEO

PR Newswire August 2, 2022

Canntab Corporate Update

PR Newswire June 30, 2022

CANNTAB ANNOUNCES CHANGE OF AUDITOR

PR Newswire May 30, 2022
View More News ››

Opinion & Analysis (CSE:PILL)

VIDEO: Extended Release Cannabis Tablets

BTV-Business Television October 2, 2018
View More Opinion ››

Bullboard Posts (CSE:PILL)

Agreement with Pathway Health

TORONTO, Dec. 2, 2021 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the...
Betteryear2 - December 2, 2021

RE:RE:Huge News

I hear you, I was expecting much more as well. Took the opportunity to buy more.  Not sure why anyone would sell on this news for a...
Druchii - November 11, 2021

RE:Huge News

I agree that it is huge news.  I have to admit though, I am a little disappointed that the share price only went up  10 cents.&...
Eppy - November 11, 2021

Huge News

This news is huge - amazing job Canntab! Company has low market cap and is the only producer with Cannabis 3.0. Seems like a multi...
Druchii - November 11, 2021

RE:Halt?

News is out. Last approval given. The company can now concentrate on production and sales.
Eppy - November 11, 2021

Halt?

ANYONE?
Bullrun - November 10, 2021
View more Bullboard ››

Leading Edge Materials Corp

Leading Edge Materials Corp

Leading Edge Materials Corp. is a Canada-based company, which is involved in the exploration and development of resource ...
View More »